FDA calls for probe of staff involved in divisive Alzheimer’s approval
US drugs watchdog was under pressure after scientific outcry over controversial Biogen treatment
Full Article
FDA calls for probe of staff involved in divisive Alzheimer’s approval
FT.com
0 shares
1 views
You might like
Related news coverage
FDA Narrows Guidance On New Alzheimer's Drug Amid Criticism
Newsy
Watch VideoThe acting head of the Food and Drug Administration on Friday called for a government investigation into highly unusual..
-
FDA head calls for inquiry into Alzheimer's drug review
SeattlePI.com
-
FDA head calls for probe into Alzheimer's drug review
SeattlePI.com